Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of 375.61 million. The enterprise value is 806.01 million.
| Market Cap | 375.61M |
| Enterprise Value | 806.01M |
Important Dates
The last earnings date was Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.10% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 327.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.93, with an EV/FCF ratio of 10.26.
| EV / Earnings | -11.95 |
| EV / Sales | 1.15 |
| EV / EBITDA | 3.93 |
| EV / EBIT | 7.11 |
| EV / FCF | 10.26 |
Financial Position
The company has a current ratio of 1.97, with a Debt / Equity ratio of 1.89.
| Current Ratio | 1.97 |
| Quick Ratio | 1.31 |
| Debt / Equity | 1.89 |
| Debt / EBITDA | 3.25 |
| Debt / FCF | 8.79 |
| Interest Coverage | 1.95 |
Financial Efficiency
Return on equity (ROE) is -14.17% and return on invested capital (ROIC) is 6.75%.
| Return on Equity (ROE) | -14.17% |
| Return on Assets (ROA) | 5.27% |
| Return on Capital (ROIC) | 6.75% |
| Revenue Per Employee | 242,117 |
| Profits Per Employee | -22,477 |
| Employee Count | 2,760 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 3.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.42% in the last 52 weeks. The beta is 1.97, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.97 |
| 52-Week Price Change | -36.42% |
| 50-Day Moving Average | 1.52 |
| 200-Day Moving Average | 1.75 |
| Relative Strength Index (RSI) | 35.53 |
| Average Volume (20 Days) | 993,001 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of 726.35 million and -67.43 million in losses. Loss per share was -0.20.
| Revenue | 726.35M |
| Gross Profit | 366.26M |
| Operating Income | 117.33M |
| Pretax Income | -853,000 |
| Net Income | -67.43M |
| EBITDA | 182.77M |
| EBIT | 117.33M |
| Loss Per Share | -0.20 |
Balance Sheet
The company has 153.30 million in cash and 690.45 million in debt, giving a net cash position of -537.15 million.
| Cash & Cash Equivalents | 153.30M |
| Total Debt | 690.45M |
| Net Cash | -537.15M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 365.37M |
| Book Value Per Share | 1.31 |
| Working Capital | 153.35M |
Cash Flow
In the last 12 months, operating cash flow was 99.69 million and capital expenditures -21.11 million, giving a free cash flow of 78.59 million.
| Operating Cash Flow | 99.69M |
| Capital Expenditures | -21.11M |
| Free Cash Flow | 78.59M |
| FCF Per Share | n/a |
Margins
Gross margin is 50.42%, with operating and profit margins of 16.15% and -9.28%.
| Gross Margin | 50.42% |
| Operating Margin | 16.15% |
| Pretax Margin | -0.12% |
| Profit Margin | -9.28% |
| EBITDA Margin | 25.16% |
| EBIT Margin | 16.15% |
| FCF Margin | 10.82% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.10% |
| Shareholder Yield | -9.10% |
| Earnings Yield | -17.98% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.06 |
| Piotroski F-Score | n/a |